靶向蛋白酪氨酸磷酸酶 22 不能增强 CAR-T 细胞在实体瘤中的疗效

Targeting Protein Tyrosine Phosphatase 22 Does Not Enhance the Efficacy of Chimeric Antigen Receptor T Cells in Solid Tumors.

Atpif1 通过调控代谢与 mtDNA-STING 信号通路在 Her2 靶向 CAR-T 细胞治疗实体瘤中的关键作用

The critical role of Atpif1 in Her2-targeted CAR-T cell therapy for solid tumor via modulation of metabolism and mtDNA-STING signal pathway.

CAR-T 细胞治疗儿童脑肿瘤：附临床试验入组标准比较分析的叙述性综述

CAR T-cell therapy in pediatric brain tumors: a narrative review with comparative analysis of clinical trial eligibility criteria.

乳腺癌管理中的 CAR-T 细胞治疗：拓展视野并克服血液系统肿瘤之外的挑战

CAR-T cell therapy in breast cancer management: expanding horizon and overcoming challenges beyond hematologic cancers.

原发性脑肿瘤的 CAR-T 细胞治疗：当前研究与未来

CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future.

利用位点特异性偶联系统构建用于 CAR-T 细胞治疗的开关模块

Construction of Switch Modules for CAR-T Cell Treatment Using a Site-Specific Conjugation System.

儿科脑肿瘤 CAR-T 细胞治疗的进展与挑战：综述

Advancements and challenges in CAR T cell therapy for pediatric brain tumors: A review.

结直肠癌和浸润性乳腺癌中 CAR-T 细胞治疗的临床新视角与挑战

Updated Clinical Perspectives and Challenges of Chimeric Antigen Receptor-T Cell Therapy in Colorectal Cancer and Invasive Breast Cancer.

经工程改造识别效应沉默型肿瘤抗原靶向人 IgG1 抗体 P329G 突变 Fc 段的 CAR-T 细胞实现实体瘤的模块化靶向

Chimeric antigen receptor T cells engineered to recognize the P329G-mutated Fc part of effector-silenced tumor antigen-targeting human IgG1 antibodies

靶向 P329G 的 CAR-T 细胞联合含 P329G Fc 突变的人 IgG1 抗原结合抗体，在不同实体瘤模型中介导了显著的体外和体内效应功能，值得进一步推进该概念的临床转化。

非信号胞外间隔区调控 CAR-T 细胞的肿瘤抗原选择性

Nonsignaling extracellular spacer regulates tumor antigen selectivity of CAR T cells.